查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗组织蛋白□ B 市场：按产品类型、按应用、按技术、按最终用户、按地区 - 规模、份额、展望、机会分析，2023-2030 年
市场调查报告书
商品编码
1350273

抗组织蛋白□ B 市场：按产品类型、按应用、按技术、按最终用户、按地区 - 规模、份额、展望、机会分析，2023-2030 年

Anti Cathepsin B Market, By Product Type, By Application, By Technique, By End User and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 255 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球抗组织蛋白□ B 市场将达到 1.87 亿美元，预测期内（2023-2030 年）复合年增长率为 3.2%。

报告范围 报告详情
基准年 2022年 2023年市场规模 美国：1.87亿美元
之前的数据 2018年至2021年 预测期 2023-2030
预测 2023-2030 年复合年增长率： 3.20% 2030年价值预测 2.337 亿美元
抗组织蛋白□ B 市场-IMG1

组织蛋白□ B 是一种半胱氨酸蛋白□，主要存在于正常细胞的溶□体中，但在许多转化细胞的质膜上分泌或与之相关。组织蛋白□ B 存在于所有动物和其他生物体中，在细胞蛋白质代谢中发挥重要作用。组织蛋白□家族包括丝胺酸蛋白□、天门冬胺酸蛋白□和半胱胺酸蛋白□。天门冬胺酸蛋白□类由组织蛋白□D和E组成，半胱氨酸蛋白□类由组织蛋白□B、L、H、K、S和O组成。目前，还没有批准的组织蛋白□抑制剂上市销售，但正在研究开发新的组织蛋白□抑制剂，用于治疗癌症、创伤性脑损伤和伊波拉感染等多种疾病。抗组织蛋白□ B 抗体主要用于治疗癌症、脑外伤、伊波拉感染和不孕症等疾病，目前正在研究作为 SARS-CoV-2 的治疗方法。组织蛋白□ B 是一种蛋白□，有助于细胞外基质重塑，从而促进伤口癒合过程中角质形成细胞的迁移。

市场动态

主要市场参与者不断增加的治疗方法、合併和收购预计将推动全球抗组织蛋白□ B 市场的成长。例如，2020年3月31日，国家生物技术资讯中心发表了一篇文章，描述组织蛋白□B（CTSB）是一种丰富的半胱氨酸蛋白□，在内溶□体区室和细胞外区域均发挥作用。许多临床前和临床研究表明CTSB与许多人类疾病有关。CTSB表现量和活性与疾病进展和严重程度有显着相关。目前的CTSB抑制剂缺乏足够的特异性和药理活性。研究人员利用基于结构的理性设计开发并生产了一种针对人类 CTSB 的人源化抗体抑制剂。

本研究的主要特点

  • 本报告详细分析了全球抗组织蛋白□B市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率（CAGR%）。
  • 它还强调了各个细分市场的潜在收入成长机会，并为该市场提供了一系列有吸引力的投资建议。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
  • 根据公司亮点、产品组合、主要亮点、绩效和策略等参数对全球抗组织蛋白□ B 市场的主要参与者进行了分析。
  • 本研究涵盖的主要公司包括Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc., and Abcam Plc.
  • 该报告的见解使行销人员和公司高管能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球抗组织蛋白□ B 市场报告迎合了该行业的各个利益相关者，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 透过用于分析全球抗组织蛋白□ B 市场的各种策略矩阵，将有助于利害关係人做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 缩略语

第二章 市场概况

  • 报告摘要
    • 市场定义和范围
  • 执行摘要
  • 连贯的机会地图 (COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进者
    • 抑製剂
    • 市场机会
  • 影响分析
  • 近期产品发布
  • 流行病学
  • 合併、收购、联盟
  • 监管场景
  • 重大发展
  • PEST分析

第四章抗组织蛋白□ B 全球市场：COVID-19 的影响分析

  • 经济影响
  • COVID-19 的流行病学
  • 对供需的影响

第五章抗组织蛋白□ B 全球市场：依产品类型，2018-2030 年

  • 一抗
  • 蛋白质和□
  • 裂解物

第六章 抗组织蛋白□ B 全球市场：依应用分类，2018-2030 年

  • 癌症
  • 创伤性脑损伤
  • 伊波拉出血热感染
  • 不孕症治疗
  • 其他

第 7 章 抗组织蛋白□ B 的全球市场：依方法划分，2018-2030 年

  • 免疫组织化学 (IHC)
  • 免疫萤光
  • 免疫印迹
  • ELISA法
  • 流式细胞仪
  • 其他

第 8 章全球抗组织蛋白□ B 市场：按最终用户划分，2018-2030 年

  • 製药公司
  • 学术/研究机构

第9章抗组织蛋白□B全球市场：依地区划分，2018-2030年

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 亚太其他地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争格局

  • Merck KGaA
  • Bio-Techne
  • BioVision Inc
  • Santa Cruz Biotechnology, Inc
  • MedChemExpress
  • BioCat GmbH
  • ApexBio Technology
  • Cayman Chemical
  • Selleck Chemicals
  • BOC Sciences
  • AG Scientific
  • Virobay Inc
  • Abcam Plc

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI4169

The Global Anti-Cathepsin B Market is estimated to be valued at US$ 187.0 Million in 2023 and is expected to exhibit a CAGR of 3.2% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 187.0 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 3.20% 2030 Value Projection: US$ 233.7 Mn
Anti Cathepsin B Market - IMG1

Cathepsin B is a cysteine protease found mainly in the lysosomes of normal cells but is secreted or associated with the plasma membrane of many transformed cells. It is found in all animals and other organisms and plays a key role in cellular protein metabolism. The cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class consists of cathepsins D and E. The cysteine protease class consists of cathepsins B, L, H, K, S, and O. Currently, there are no approved cathepsin inhibitors on the market, but research is ongoing to develop new cathepsin inhibitors for the treatment of various diseases such as cancer, traumatic brain injury, Ebola infection, and others. Anti-Cathespin B antibodies are majorly used for the treatment of disease conditions such as cancer, traumatic brain injury, Ebola infection, and fertility problems, and are currently under research for the treatment of SARS-CoV-2. Cathepsin B is a protease that contributes to the remodeling of the extracellular matrix and thereby promotes keratinocyte migration during wound healing.

Market Dynamics

Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global anti-cathepsin B market growth. For instance, on March 31, 2020, National Center for Biotechnology Information published an article explaining Cathepsin B (CTSB) is an abundant cysteine protease that functions in both endolysosomal compartments and extracellular regions. Many preclinical and clinical studies indicate that CTSB is involved in many human diseases. CTSB expression levels and activity are significantly correlated with disease progression and severity. Current CTSB inhibitors lack sufficient specificity and pharmacological activity. Using structure-based rational design, researchers developed and produced a humanized antibody inhibitor targeting human CTSB.

Key features of the study:

  • This report provides an in-depth analysis of the global anti-cathepsin B market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global anti-cathepsin B market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc., and Abcam Plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global anti-cathepsin B market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-cathepsin B market.

Detailed Segmentation:

  • Global Anti-Cathepsin B Market, By Product Type :
    • Primary Antibodies
    • Proteins and Peptides
    • Lysates
  • Global Anti-Cathepsin B Market, By Application :
    • Cancer
    • Traumatic Brain Injury
    • Ebola Infection
    • Fertility Treatment
    • Others
  • Global Anti-Cathepsin B Market, By Technique :
    • Immunohistochemistry
    • Immunofluorescence
    • Western Blotting
    • ELISA
    • Flow Cytometry
    • Others
  • Global Anti-Cathepsin B Market, By End User
    • Pharmaceutical Companies
    • Academic and Research Institutes
  • Global Anti-Cathepsin B Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Merck KGaA
    • Bio-Techne
    • BioVision Inc.
    • Santa Cruz Biotechnology, Inc.
    • MedChemExpress
    • BioCat GmbH
    • ApexBio Technology
    • Cayman Chemical
    • Selleck Chemicals
    • BOC Sciences
    • AG Scientific
    • Virobay Inc.
    • Abcam Plc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By Technique
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Anti-Cathepsin B Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Anti-Cathepsin B Market, By Product Type, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Primary Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Proteins and Peptides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Lysates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Anti-Cathepsin B Market, By Application, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Traumatic Brain Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Ebola Infection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Fertility Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Anti-Cathepsin B Market, By Technique, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Immunohistochemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Immunofluorescence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Western Blotting
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • ELISA
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Flow Cytometry
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Others
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends

8. Global Anti-Cathepsin B Market, By End User, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Pharmaceutical Companies
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Academic and Research Institutes
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends

9. Global Anti-Cathepsin B Market, By Region, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Techne
  • BioVision Inc
  • Santa Cruz Biotechnology, Inc
  • MedChemExpress
  • BioCat GmbH
  • ApexBio Technology
  • Cayman Chemical
  • Selleck Chemicals
  • BOC Sciences
  • AG Scientific
  • Virobay Inc
  • Abcam Plc

11. Section

  • Research Methodology
  • About Us